edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
IRLAB has announced that all patients enrolled in the REACT-PD trial have completed treatment and had their final follow-up visit. This Phase IIb study is evaluating IRLAB’s prefrontal cortex enhancer, pirepemat, as a potential therapy to improve balance and reduce falls in Parkinson’s disease patients. Top-line results are due to be reported in Q125, consistent with prior guided timelines for the trial.
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.